Showing 13 - 16 of 16 results
Previous| 1 | 2 |Next
Exclusive to Roswell Park, ‘Armored CAR’ Clinical Trial Targets CD19+ Hematologic Malignancies
Roswell Park Provides Support, Clinical Trials for Young Adult Sarcoma Patients
FDA Expands Orphan Drug Designation for SurVaxM, Immunotherapy Developed at Roswell Park.
Next Generation Armored Car T-Cell Therapy Trial Now Open
BROADCASTMED